S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Options Trading Plan–Perfect For Beginners (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
BREAKING: Tiny biotech successfully treats blindness (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Options Trading Plan–Perfect For Beginners (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
BREAKING: Tiny biotech successfully treats blindness (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Options Trading Plan–Perfect For Beginners (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
BREAKING: Tiny biotech successfully treats blindness (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Options Trading Plan–Perfect For Beginners (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
BREAKING: Tiny biotech successfully treats blindness (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
NYSE:CNMD

CONMED (CNMD) Stock Forecast, Price & News

$101.15
-0.27 (-0.27%)
(As of 09/22/2023 ET)
Compare
Today's Range
$99.95
$101.97
50-Day Range
$101.18
$134.25
52-Week Range
$71.09
$138.47
Volume
364,884 shs
Average Volume
271,114 shs
Market Capitalization
$3.11 billion
P/E Ratio
35.74
Dividend Yield
0.79%
Price Target
$135.67

CONMED MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
34.1% Upside
$135.67 Price Target
Short Interest
Bearish
13.08% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-0.74
Upright™ Environmental Score
News Sentiment
0.74mentions of CONMED in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$366,380 Sold Last Quarter
Proj. Earnings Growth
25.94%
From $3.47 to $4.37 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.72 out of 5 stars

Medical Sector

84th out of 963 stocks

Electromedical Equipment Industry

2nd out of 22 stocks


CNMD stock logo

About CONMED (NYSE:CNMD) Stock

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

CNMD Price History

CNMD Stock News Headlines

CONMED (NYSE:CNMD) Upgraded by StockNews.com to Hold
CONMED Co. (NYSE:CNMD) Insider Sells $214,620.00 in Stock
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
CONMED (NYSE:CNMD) Downgraded by StockNews.com to Sell
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk
I recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.
Conmed (NYSE: CNMD)
CONMED (CNMD) Beats on Q2 Earnings, Ups '23 EPS View
Conmed Corp. Q2 Earnings Summary
Conmed: Q2 Earnings Snapshot
Analyst Ratings for Conmed
Conmed: Updated Guidance Is Positive
When Should You Buy CONMED Corporation (NYSE:CNMD)?
See More Headlines
Receive CNMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter.

CNMD Company Calendar

Ex-Dividend for 7/5 Dividend
6/14/2023
Dividend Payable
7/05/2023
Last Earnings
7/26/2023
Ex-Dividend for 10/5 Dividend
9/14/2023
Today
9/24/2023
Dividend Payable
10/05/2023
Next Earnings (Estimated)
10/25/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Employees
4,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$135.67
High Stock Price Forecast
$145.00
Low Stock Price Forecast
$119.00
Forecasted Upside/Downside
+34.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$-80,580,000.00
Pretax Margin
2.20%

Debt

Sales & Book Value

Annual Sales
$1.05 billion
Cash Flow
$5.23 per share
Book Value
$24.46 per share

Miscellaneous

Free Float
28,404,000
Market Cap
$3.11 billion
Optionable
Optionable
Beta
1.38
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Curt R. HartmanMr. Curt R. Hartman (Age 59)
    Chairman, CEO & Pres
    Comp: $1.5M
  • Mr. Todd W. GarnerMr. Todd W. Garner (Age 54)
    Exec. VP & CFO
    Comp: $783.48k
  • Ms. Heather L. Cohen (Age 50)
    Exec. VP and Chief HR & Legal Officer
    Comp: $561.01k
  • Mr. Patrick J. Beyer (Age 57)
    Pres of International & Global Orthopedics
    Comp: $1.22M
  • Mr. Stanley W. Peters IIIMr. Stanley W. Peters III (Age 48)
    Pres of Advanced Surgical & Advanced Endoscopic Technologies
    Comp: $648.12k
  • Mr. Peter K. Shagory (Age 54)
    Exec. VP of Strategy & Corp. Devel.
  • Ms. Shanna L. Cotti-Osmanski (Age 46)
    Exec. VP of Information Technology & CIO
  • Mr. Brent Lalomia (Age 48)
    Exec. VP of Quality Assurance & Regulatory Affairs
  • Mr. John Ferrell (Age 55)
    Exec. VP of HR
  • Mr. Daniel S. Jonas Esq. (Age 59)
    Special Counsel & Corp. Sec.













CNMD Stock - Frequently Asked Questions

Should I buy or sell CONMED stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CNMD shares.
View CNMD analyst ratings
or view top-rated stocks.

What is CONMED's stock price forecast for 2023?

5 analysts have issued 1-year price targets for CONMED's stock. Their CNMD share price forecasts range from $119.00 to $145.00. On average, they expect the company's share price to reach $135.67 in the next twelve months. This suggests a possible upside of 34.1% from the stock's current price.
View analysts price targets for CNMD
or view top-rated stocks among Wall Street analysts.

How have CNMD shares performed in 2023?

CONMED's stock was trading at $88.64 at the start of the year. Since then, CNMD stock has increased by 14.1% and is now trading at $101.15.
View the best growth stocks for 2023 here
.

When is CONMED's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 25th 2023.
View our CNMD earnings forecast
.

How were CONMED's earnings last quarter?

CONMED Co. (NYSE:CNMD) posted its quarterly earnings data on Wednesday, July, 26th. The company reported $0.83 earnings per share for the quarter, beating analysts' consensus estimates of $0.79 by $0.04. The business earned $317.70 million during the quarter, compared to analyst estimates of $306.15 million. CONMED had a trailing twelve-month return on equity of 11.14% and a net margin of 7.75%. The firm's revenue was up 14.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.76 earnings per share.

How often does CONMED pay dividends? What is the dividend yield for CONMED?

CONMED announced a quarterly dividend on Thursday, August 10th. Shareholders of record on Friday, September 15th will be given a dividend of $0.20 per share on Thursday, October 5th. This represents a $0.80 dividend on an annualized basis and a yield of 0.79%. The ex-dividend date of this dividend is Thursday, September 14th.
Read our dividend analysis for CNMD
.

Is CONMED a good dividend stock?

CONMED (NYSE:CNMD) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.79%. The dividend payout ratio is 28.27%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CNMD will have a dividend payout ratio of 18.31% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CNMD.

What guidance has CONMED issued on next quarter's earnings?

CONMED issued an update on its FY23 earnings guidance on Wednesday, July, 26th. The company provided earnings per share (EPS) guidance of $3.40-$3.55 for the period, compared to the consensus EPS estimate of $3.42. The company issued revenue guidance of $1.23-$1.26 billion, compared to the consensus revenue estimate of $1.23 billion.

What is CONMED's stock symbol?

CONMED trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNMD."

Who are CONMED's major shareholders?

CONMED's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Capital Research Global Investors (8.04%), Earnest Partners LLC (7.23%), Champlain Investment Partners LLC (3.07%), Dimensional Fund Advisors LP (2.19%), Principal Financial Group Inc. (2.07%) and Geode Capital Management LLC (1.91%). Insiders that own company stock include Brian Concannon, Curt R Hartman, Daniel S Jonas, John D Ferrell, Johonna Marie Pelletier, Peter K Shagory, Stanley W Peters III, Todd W Garner and Todd W Garner.
View institutional ownership trends
.

How do I buy shares of CONMED?

Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CONMED's stock price today?

One share of CNMD stock can currently be purchased for approximately $101.15.

How much money does CONMED make?

CONMED (NYSE:CNMD) has a market capitalization of $3.11 billion and generates $1.05 billion in revenue each year. The company earns $-80,580,000.00 in net income (profit) each year or $2.83 on an earnings per share basis.

How many employees does CONMED have?

The company employs 4,100 workers across the globe.

How can I contact CONMED?

CONMED's mailing address is 525 FRENCH ROAD, UTICA NY, 13502. The official website for the company is www.conmed.com. The company can be reached via phone at (727) 392-6464 or via fax at 315-797-0321.

This page (NYSE:CNMD) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -